hypoxia activated inhibitors (Sentinel Oncology)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Namehypoxia activated inhibitors (Sentinel Oncology)

Drug Alias NameKdr/Aurora A inhibitors (Sentinel Oncology)S-081S-091

ClassificationSmall molecules

Mechanisms of ActionSerine/threonine-protein kinase Aurora-A inhibitorsAnticancer protein kinase inhibitorsVascular endothelial growth factor receptor 2 antagonists

TargetsVascular endothelial growth factor receptor 2Serine/threonine-protein kinase Aurora-A

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSentinel Oncology Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSentinel Oncology Ltd

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A